|
|
Article: Spectrum Announces Strategic Alliance with Par Pharmaceutical Companies, Inc. for Sales and Distribution of Spectrum's Generic Product Line.
- Article from:
- PR Newswire
- Article date:
- February 23, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
* Spectrum to receive over $10 million in milestone payments on achievement of specified regulatory approvals and equity investment
* Agreement covers both current and future generic drugs, including sumatriptan injection filed with Paragraph IV certification
* PAR will assume all financial responsibility for litigation with GSK related to the sumatriptan injection paragraph IV filing
* Spectrum and PAR will share profits from the sale of Spectrum's generic drugs
IRVINE, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. today announced that it has entered into a strategic alliance with Par Pharmaceutical ...